Collectively, these findings suggest that CCR8 function does not substantially affect anti‐tumour immune responses in the syngeneic MC38 colorectal adenocarcinoma model, despite its sensitivity to Treg cell ablation. This evidence concerns the gene CCR8 and neoplasm.